Otsuka Holdings Announces Collaboration with ReCor Medical for Commercialization of ReCor Medical’s Ultrasound Renal...
Otsuka Holdings Co Ltd announced the signing of a development and commercialization agreement with ReCor...
Biogen Announces Collaboration with University of Pennsylvania on Multiple Gene Therapy Programs
Visionary, up to $2 billion multi-year alliance to focus on development of new gene...
Pfizer reports Results From Two Phase 3 TRUMENBA (Meningococcal Group B Vaccine) Studies At...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal...
Pfizer Announces Results From Two Phase 3 TRUMENBA Studies At The European Society...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal...
EU approves Alprolix (rFIXFc) for the Treatment of Haemophilia B
First Fc Fusion Therapy Approved for haemophilia B in the EU to Provide Extended Protection...
Immunosup pressant CellCept Obtained Approval for Additional Indication of “Lupus Nephritis”
Chugai Pharmaceutical Co Ltd. announced that it obtained a supplemental approval from the Japanese Ministry...
Chugai Pharmaceutical Co Ltd. to Take Part in “Relay for Life Japan” Using “3D...
Chugai Pharmaceutical Co Ltd announced that its co-sponsorship of “Relay for Life Japan” (Organizer: Japan...
AbbVie Inc to participate at the UBS Global Health Care Conference
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill...
Mylan Launches Generic Frova Tablets for for migraine headaches in adults.
Mylan N.V. announced the U.S. launch of Frovatriptan Succinate Tablets 2.5 mg, a generic version...
Johnson & Johnson opens first international JLABs site in Canada
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot...